Editas Medicine, Inc. (NASDAQ:EDIT) showed up in the 13F filings of 187 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 9,347,114 | 1,327,223 | 16.55% | $19,161,582.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 9,263,312 | -83,802 | -0.90% | $22,880,381.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 8,208,068 | 1,242,450 | 17.84% | $16,826,539.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 4,204,369 | 4,204,369 | 0.00% | $10,384,791.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 3,972,160 | 932,382 | 30.67% | $9,811,235.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Dec, 2025 | 3,148,570 | 3,148,570 | 0.00% | $7,776,968.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 3,039,778 | 1,762,378 | 137.97% | $6,231,545.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 2,311,789 | 27,049 | 1.18% | $5,711,437.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 2,284,740 | 244,574 | 11.99% | $4,684,759.00 |
| State Street Corp | 31 Dec, 2025 | 2,076,122 | 101,191 | 5.12% | $5,128,021.00 |
| Nuveen, LLC | 31 Dec, 2025 | 1,977,509 | 609 | 0.03% | $4,884,447.00 |
| Nuveen, LLC | 31 Dec, 2025 | 1,976,900 | -114,736 | -5.49% | $4,052,645.00 |
| State Street Corp | 31 Dec, 2025 | 1,974,931 | 49,887 | 2.59% | $4,048,609.00 |
| Jpmorgan Chase & Co | 31 Dec, 2025 | 1,947,384 | 1,164,280 | 148.68% | $4,342,666.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 1,943,893 | 834,303 | 75.19% | $4,801,415.00 |
| Opaleye Management Inc. | 31 Dec, 2025 | 1,926,997 | 1,926,997 | 0.00% | $4,759,683.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 1,763,920 | 1,305,644 | 284.90% | $3,616,036.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 1,632,584 | 48,429 | 3.06% | $3,346,797.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 1,549,063 | -83,521 | -5.12% | $3,826,186.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 1,457,715 | 657,868 | 82.25% | $3,596.00 |